Literature DB >> 17058214

Different signaling pathways in the livers of patients with chronic hepatitis B or chronic hepatitis C.

Masao Honda1, Taro Yamashita, Teruyuki Ueda, Hajime Takatori, Ryuhei Nishino, Shuichi Kaneko.   

Abstract

The clinical manifestations of chronic hepatitis B (CH-B) and chronic hepatitis C (CH-C) are different. We previously reported differences in the gene expression profiles of liver tissue infected with CH-B or CH-C; however, the signaling pathways underlying each condition have yet to be clarified. Using a newly constructed cDNA microarray consisting of 9614 clones selected from 256,550 tags of hepatic serial analysis of gene expression (SAGE) libraries, we compared the gene expression profiles of liver tissue from 24 CH-B patients with those of 23 CH-C patients. Laser capture microdissection was used to isolate hepatocytes from liver lobules and infiltrating lymphoid cells from the portal area, from 16 patients, for gene expression analysis. Furthermore, the comprehensive gene network was analyzed using SAGE libraries of CH-B and CH-C. Supervised and nonsupervised learning methods revealed that gene expression was correlated more with the infecting virus than any other clinical parameters such as histological stage and disease activity. Pro-apoptotic and DNA repair responses were predominant in CH-B with p53 and 14-3-3 interacting genes having an important role. In contrast, inflammatory and anti-apoptotic phenotypes were predominant in CH-C. These differences would evoke different oncogenic factors in CH-B and CH-C. In conclusion, we describe the different signaling pathways induced in the livers of patients with CH-B or CH-C. The results might be useful in guiding therapeutic strategies to prevent the development of hepatocellular carcinoma in cases of CH-B and CH-C.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17058214     DOI: 10.1002/hep.21383

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  25 in total

1.  Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection.

Authors:  Xiaoming Cheng; Takuro Uchida; Yuchen Xia; Regina Umarova; Chun-Jen Liu; Pei-Jer Chen; Anuj Gaggar; Vithika Suri; Marcus M Mücke; Johannes Vermehren; Stefan Zeuzem; Yuji Teraoka; Mitsutaka Osawa; Hiroshi Aikata; Keiji Tsuji; Nami Mori; Shuhei Hige; Yoshiyasu Karino; Michio Imamura; Kazuaki Chayama; T Jake Liang
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

Review 2.  Molecular classification and novel targets in hepatocellular carcinoma: recent advancements.

Authors:  Yujin Hoshida; Sara Toffanin; Anja Lachenmayer; Augusto Villanueva; Beatriz Minguez; Josep M Llovet
Journal:  Semin Liver Dis       Date:  2010-02-19       Impact factor: 6.115

Review 3.  MiR-122 in hepatitis B virus and hepatitis C virus dual infection.

Authors:  Kyoungsub Song; Chang Han; Srikanta Dash; Luis A Balart; Tong Wu
Journal:  World J Hepatol       Date:  2015-03-27

4.  5-Hydroxytryptamine promotes hepatocellular carcinoma proliferation by influencing β-catenin.

Authors:  Sarwat Fatima; Xiaoke Shi; Zesi Lin; Guo-qing Chen; Xiao-hua Pan; Justin Che-Yuen Wu; John W Ho; Nikki P Lee; Hengjun Gao; Ge Zhang; Aiping Lu; Zhao Xiang Bian
Journal:  Mol Oncol       Date:  2015-09-30       Impact factor: 6.603

5.  Differential alteration of CD56(bright) and CD56 (dim) natural killer cells in frequency, phenotype, and cytokine response in chronic hepatitis C virus infection.

Authors:  Takuya Miyagi; Satoshi Shimizu; Tomohide Tatsumi; Kumiko Nishio; Naoki Hiramatsu; Tatsuya Kanto; Norio Hayashi; Tetsuo Takehara
Journal:  J Gastroenterol       Date:  2011-05-11       Impact factor: 7.527

Review 6.  Viral hepatocarcinogenesis.

Authors:  W-L Tsai; R T Chung
Journal:  Oncogene       Date:  2010-03-15       Impact factor: 9.867

7.  Molecular classification of hepatocellular carcinoma: potential therapeutic implications.

Authors:  Nicolas Goossens; Xiaochen Sun; Yujin Hoshida
Journal:  Hepat Oncol       Date:  2015

8.  Defining disease with laser precision: laser capture microdissection in gastroenterology.

Authors:  Richard Blatt; Shanthi Srinivasan
Journal:  Gastroenterology       Date:  2008-07-09       Impact factor: 22.682

9.  Intrahepatic gene expression profiles in chronic hepatitis B and autoimmune liver disease.

Authors:  Keiko Furuta; Sayaka Sato; Taeko Yamauchi; Takuya Ozawa; Manabu Harada; Shinichi Kakumu
Journal:  J Gastroenterol       Date:  2008-11-18       Impact factor: 7.527

10.  Establishment of liver tumor cell lines from atherogenic and high fat diet fed hepatitis C virus transgenic mice.

Authors:  Takayoshi Shirasaki; Kazuhisa Murai; Masao Honda; Hikari Okada; Yuika Innami; Atsumu Yamada; Tetsuro Shimakami; Kazunori Kawaguchi; Taro Yamashita; Yoshio Sakai; Shuichi Kaneko
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.